Thymidine
( DrugBank: Thymidine / KEGG DRUG: Doxribtimine )
2 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 215 | Tetralogy of Fallot | 2 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 216 | Double-outlet right ventricle | 1 |
215. Tetralogy of Fallot
Clinical trials : 28 / Drugs : 55 - (DrugBank : 19) / Drug target genes : 16 - Drug target pathways : 50
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
216. Double-outlet right ventricle
Clinical trial : 1 / Drugs : 9 - (DrugBank : 2) / Drug target genes : 4 - Drug target pathways : 16
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|